Hantz Financial Services Inc. Buys 6,478 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Hantz Financial Services Inc. grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 8.0% during the third quarter, HoldingsChannel.com reports. The fund owned 87,258 shares of the healthcare conglomerate’s stock after acquiring an additional 6,478 shares during the quarter. UnitedHealth Group comprises 0.9% of Hantz Financial Services Inc.’s investment portfolio, making the stock its 19th biggest position. Hantz Financial Services Inc.’s holdings in UnitedHealth Group were worth $51,018,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the business. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter valued at $27,000. Global Wealth Strategies & Associates raised its holdings in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the period. Macroview Investment Management LLC grew its position in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares during the last quarter. West Financial Advisors LLC bought a new position in UnitedHealth Group in the third quarter worth approximately $32,000. Finally, Bbjs Financial Advisors LLC bought a new stake in UnitedHealth Group during the 2nd quarter valued at $31,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded up $1.59 during trading on Thursday, hitting $608.38. 2,269,792 shares of the stock traded hands, compared to its average volume of 3,865,617. The company has a fifty day moving average price of $584.09 and a two-hundred day moving average price of $555.02. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a market cap of $559.88 billion, a price-to-earnings ratio of 39.63, a P/E/G ratio of 1.78 and a beta of 0.58. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the prior year, the company posted $6.56 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.38%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is presently 54.72%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Morgan Stanley decreased their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Barclays increased their price target on UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research note on Wednesday. UBS Group decreased their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, November 20th. Finally, Truist Financial reissued a “buy” rating and set a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $618.26.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.